The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre
- PMID: 24719216
- DOI: 10.1177/0004563214529937
The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre
Abstract
Background: Urine oxalate measurement is an important investigation in the evaluation of renal stone disease. Primary hyperoxaluria (PH) is a rare inherited metabolic disease characterised by persistently elevated urine oxalate, but the diagnosis may be missed in adults until renal failure has developed. Urine oxalate results were reviewed to compare oxalate:creatinine ratio and oxalate excretion, and to estimate the potential numbers of undiagnosed PH.
Methods: Urine oxalate results from August 2011 to April 2013 were reviewed. Oxalate excretion and oxalate:creatinine ratio were evaluated for 24 h collections and ratio alone for spot urine samples.
Results: Oxalate:creatinine ratio and oxalate excretion were moderately correlated (R=0.63) in 24-h urine collections from patients aged 18 years and above. Sex-related differences were found requiring implementation of male and female reference ranges for oxalate:creatinine ratio. Of samples with both ratio and excretion above the reference range, 7% came from patients with confirmed PH. There were 24 patients with grossly elevated urine oxalate who had not been evaluated for PH.
Conclusions: Oxalate:creatinine ratio and oxalate excretion were discordant in many patients, which is likely to be a result of intra-individual variation in creatinine output and imprecision in the collection itself. Some PH patients had urine oxalate within the reference range on occasion, and therefore it is not possible to exclude PH on the finding of a single normal result. A significant number of individuals had urine oxalate results well above the reference range who potentially have undiagnosed PH and are consequently at risk of renal failure.
Keywords: Clinical studies; Renal disease; inborn errors of metabolism.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Similar articles
-
Urine oxalate biological variation in patients with primary hyperoxaluria.Urolithiasis. 2016 Aug;44(4):333-7. doi: 10.1007/s00240-016-0860-2. Epub 2016 Feb 8. Urolithiasis. 2016. PMID: 26857252
-
The urinary response to an oral oxalate load in recurrent calcium stone formers.J Urol. 2003 Jun;169(6):2030-3. doi: 10.1097/01.ju.0000062527.37579.49. J Urol. 2003. PMID: 12771711
-
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.Nephrol Dial Transplant. 2011 Nov;26(11):3609-15. doi: 10.1093/ndt/gfr107. Epub 2011 Apr 2. Nephrol Dial Transplant. 2011. PMID: 21460356 Clinical Trial.
-
Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.Scand J Urol Nephrol Suppl. 1989;119:1-53. Scand J Urol Nephrol Suppl. 1989. PMID: 2669121 Review.
-
The primary hyperoxalurias: an algorithm for diagnosis.Am J Nephrol. 2005 Mar-Apr;25(2):154-60. doi: 10.1159/000085407. Epub 2005 Apr 22. Am J Nephrol. 2005. PMID: 15855742 Review.
Cited by
-
Urine oxalate biological variation in patients with primary hyperoxaluria.Urolithiasis. 2016 Aug;44(4):333-7. doi: 10.1007/s00240-016-0860-2. Epub 2016 Feb 8. Urolithiasis. 2016. PMID: 26857252
-
Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G82-G94. doi: 10.1152/ajpgi.00299.2018. Epub 2018 Nov 1. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 30383413 Free PMC article.
-
Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing.Mol Genet Genomic Med. 2015 Jan;3(1):69-78. doi: 10.1002/mgg3.118. Mol Genet Genomic Med. 2015. PMID: 25629080 Free PMC article.
-
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.Nat Rev Nephrol. 2023 Mar;19(3):194-211. doi: 10.1038/s41581-022-00661-1. Epub 2023 Jan 5. Nat Rev Nephrol. 2023. PMID: 36604599 Review.
-
Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria.Pediatr Nephrol. 2017 Nov;32(11):2159-2163. doi: 10.1007/s00467-017-3741-1. Epub 2017 Jul 27. Pediatr Nephrol. 2017. PMID: 28752386
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous